Recombinant Human Cyclin-Dependent Kinase Inhibitor 1/CDKN1A/p21 (C-6His)

Recombinant Human Cyclin-Dependent Kinase Inhibitor 1/CDKN1A/p21 (C-6His)

SKU: CE72-10ug
Recombinant Human p21 Cyclin Dependent Kinase 4 Inhibitor 1A is produced by our E.coli expression system and the target gene encoding Ser2-Pro164 is expressed with a 6His tag at the C-terminus. Bon Opus Cat. #CE72
  • Accession Number

  • Background

    Cyclin-Dependent Kinase Inhibitor 1 (CDKN1A) is a member of the CDI family. CDKN1A is widely expressed in all adult tissues, but low expressed in the brain tissue. CDKN1A can be induced by p53/TP53, mezerein and IFNB1, repressed by HDAC1. CDKN1A may be an important intermediate, by which p53/TP53 mediates its role as an inhibitor of cellular proliferation in response to DNA damage, CDKN1A can bind to and inhibit cyclin-dependent kinase activity, preventing phosphorylation of critical cyclin-dependent kinase substrates and blocking cell cycle progression.
  • Expression

  • Packaging

  • Formulation

    Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.2.
  • ALTnames

    Cyclin-Dependent Kinase Inhibitor 1, CDK-Interacting Protein 1, Melanoma Differentiation-Associated Protein 6, MDA-6, p21, CDKN1A, CAP20, CDKN1, CIP1, MDA6, PIC1, SDI1, WAF1
  • Twitter
  • Facebook
  • LinkedIn

Terms and Conditions  I  Privacy Policy  I  Legal  I  Sitemap ©2020 by Bon Opus Biosciences, LLC.     150 Essex St, Millburn, NJ 07041, USA